| - GRCh37:
- Chr15:83349719
- GRCh38:
- Chr15:82680967
| AP3B2, CPEB1-AS1 | I182fs, I214fs | Developmental and epileptic encephalopathy, 48 | Pathogenic (Jul 14, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83330664
- GRCh38:
- Chr15:82661912
| AP3B2, CPEB1-AS1 | R21*, R926*, R958*, R977* | Developmental and epileptic encephalopathy, 48 | Pathogenic (Nov 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83335601
- GRCh38:
- Chr15:82666849
| AP3B2, CPEB1-AS1 | Q552*, Q584* | Developmental and epileptic encephalopathy, 48 | Likely pathogenic (Nov 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83348922
- GRCh38:
- Chr15:82680170
| AP3B2, CPEB1-AS1 | | Developmental and epileptic encephalopathy, 48 | Uncertain significance (Nov 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83348924
- GRCh38:
- Chr15:82680172
| AP3B2, CPEB1-AS1 | | not provided, Developmental and epileptic encephalopathy, 48 | Uncertain significance (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83334221-83334222
- GRCh38:
- Chr15:82665469-82665470
| AP3B2, CPEB1-AS1 | V653fs, V621fs | not provided, Developmental and epileptic encephalopathy, 48 | Pathogenic/Likely pathogenic (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83346141
- GRCh38:
- Chr15:82677389
| AP3B2, CPEB1-AS1 | | Developmental and epileptic encephalopathy, 48, not provided | Conflicting interpretations of pathogenicity (Jul 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:83378366
- GRCh38:
- Chr15:82709614
| AP3B2, LOC130057772 | | not provided, Developmental and epileptic encephalopathy, 48 | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83335584
- GRCh38:
- Chr15:82666832
| AP3B2, CPEB1-AS1 | | not provided, Developmental and epileptic encephalopathy, 48 | Conflicting interpretations of pathogenicity (Oct 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:83331884
- GRCh38:
- Chr15:82663132
| AP3B2, CPEB1-AS1 | P816S, P848S, P867S | Developmental and epileptic encephalopathy, 48 | Uncertain significance (Feb 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83350239
- GRCh38:
- Chr15:82681487
| AP3B2, CPEB1-AS1 | E120*, E152* | Developmental and epileptic encephalopathy, 48 | Likely pathogenic (Mar 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83350245-83350248
- GRCh38:
- Chr15:82681493-82681496
| AP3B2, CPEB1-AS1 | A117fs, A149fs | not provided | Pathogenic (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83357481
- GRCh38:
- Chr15:82688729
| CPEB1-AS1, AP3B2 | | Developmental and epileptic encephalopathy, 48 | Uncertain significance (Sep 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83330663
- GRCh38:
- Chr15:82661911
| AP3B2, CPEB1-AS1 | R21Q, R926Q, R958Q, R977Q | not provided, Developmental and epileptic encephalopathy, 48 | Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83331600
- GRCh38:
- Chr15:82662848
| AP3B2, CPEB1-AS1 | D842E, D874E, D893E | Developmental and epileptic encephalopathy, 48, not provided | Uncertain significance (Jun 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83331646
- GRCh38:
- Chr15:82662894
| AP3B2, CPEB1-AS1 | R827Q, R859Q, R878Q | Developmental and epileptic encephalopathy, 48, not provided | Conflicting interpretations of pathogenicity (Oct 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:83345242
- GRCh38:
- Chr15:82676490
| AP3B2, CPEB1-AS1 | A514P, A546P | Developmental and epileptic encephalopathy, 48, not provided | Uncertain significance (Mar 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83346938
- GRCh38:
- Chr15:82678186
| AP3B2, CPEB1-AS1 | | Developmental and epileptic encephalopathy, 48, not provided | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:83349339
- GRCh38:
- Chr15:82680587
| AP3B2, CPEB1-AS1 | Q282*, Q314* | Developmental and epileptic encephalopathy, 48 | Pathogenic (Jun 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83328325
- GRCh38:
- Chr15:82659573
| AP3B2, CPEB1-AS1 | A1098D, A1047D, A1079D, A142D | Developmental and epileptic encephalopathy, 48, not provided | Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83330614-83330615
- GRCh38:
- Chr15:82661862-82661863
| AP3B2, CPEB1-AS1 | P37fs, P942fs, P974fs, P993fs | not provided, Developmental and epileptic encephalopathy, 48 | Pathogenic/Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83349398
- GRCh38:
- Chr15:82680646
| AP3B2, CPEB1-AS1 | K262T, K294T | Developmental and epileptic encephalopathy, 48, Gastroesophageal reflux, Abnormality of speech or vocalization, Generalized hypotonia, Abnormality of eye movement, Autism, Delayed speech and language development, Global developmental delay, Hypotonia, Feeding difficulties, Microcephalynot provided, ...see more | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83350299-83350301
- GRCh38:
- Chr15:82681547-82681549
| AP3B2, CPEB1-AS1 | L99del, L131del | Developmental and epileptic encephalopathy, 48 | Likely pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83349685-83349686
- GRCh38:
- Chr15:82680933-82680934
| AP3B2, CPEB1-AS1 | | Developmental and epileptic encephalopathy, 48 | Likely pathogenic (Nov 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83328609
- GRCh38:
- Chr15:82659857
| AP3B2, CPEB1-AS1 | S92Y, S1029Y, S1048Y, S997Y | not provided, Developmental and epileptic encephalopathy, 48 | Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:83328587
- GRCh38:
- Chr15:82659835
| AP3B2, CPEB1-AS1 | | not provided, Developmental and epileptic encephalopathy, 48 | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:83335514
- GRCh38:
- Chr15:82666762
| AP3B2, CPEB1-AS1 | E613fs, E581fs | Developmental and epileptic encephalopathy, 48 | Pathogenic (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83357975
- GRCh38:
- Chr15:82689223
| AP3B2, CPEB1-AS1 | R67* | Developmental and epileptic encephalopathy, 48 | Pathogenic (Nov 19, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:83331901-83331904
- GRCh38:
- Chr15:82663149-82663152
| AP3B2, CPEB1-AS1 | L809fs, L841fs, L860fs | Developmental and epileptic encephalopathy, 48 | Pathogenic (Nov 19, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:83343184-83345634
- GRCh38:
- Chr15:82674432-82676882
| AP3B2, CPEB1-AS1 | | Developmental and epileptic encephalopathy, 48 | Pathogenic (Nov 19, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:83348926
- GRCh38:
- Chr15:82680174
| AP3B2, CPEB1-AS1 | | Epileptic encephalopathy | Likely pathogenic (Jan 1, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr15:83348481
- GRCh38:
- Chr15:82679729
| AP3B2, CPEB1-AS1 | | Developmental and epileptic encephalopathy, 48, Epileptic encephalopathy | Pathogenic/Likely pathogenic (Nov 19, 2020) | no assertion criteria provided |